Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial
Research output: Contribution to journal › Journal article › Research › peer-review
The aim of the study was to compare changes in bone mineral density (BMD) over 144 weeks in HIV-infected patients initiating nucleoside reverse transcriptase inhibitor (NRTI)-sparing or protease inhibitor-sparing highly active antiretroviral therapy (HAART).
| Original language | English |
|---|---|
| Journal | HIV Medicine |
| Volume | 12 |
| Issue number | 3 |
| Pages (from-to) | 157-65 |
| Number of pages | 9 |
| ISSN | 1464-2662 |
| DOIs | |
| Publication status | Published - 1 Mar 2011 |
ID: 40155059